Quetiapine showed to be an effective adjunctive treatment in addressing comorbid anxiety with depressive disorders, according to a randomized, placebo-controlled study published in the Journal of Clinical Psychiatry.
“Comorbidity of anxiety and depression is associated with poorer outcomes for both illnesses, including greater severity, protracted course and more functional impairment than with either alone,” Nisha Ravindran, MD, of the Centre for Addiction and Mental Health in Toronto, and colleagues wrote.
Researchers sought to assess the safety and tolerability of quetiapine in